Vepesid

Bristol Myers Squibb is a leading global biopharmaceutical company headquartered in Princeton, New Jersey. The company specializes in the discovery, development, and delivery of innovative medicines across several therapeutic areas, including oncology, hematology, immunology, and cardiovascular disease. Its extensive portfolio features high-profile drugs such as Opdivo, Eliquis, and the chemotherapy agent Vepesid. Through strategic acquisitions like Celgene, BMS has significantly expanded its pipeline in cell therapy and oncology. The company remains a major player in the pharmaceutical industry, focusing on high-unmet-need disease areas.